Furthermore,
Sensorion finalizes recruitment patients second new: Moreover,
Sensorion finalizes recruitment patients second:
Montpellier. Furthermore. Therefore, July 29, 2025, 7:30 am this-Sensorion (FR0012596468-Alsen), a pioneer company of biotechnology at the clinical stage, specialized in the development of new therapies to restore, process and prevent auditory loss disorders, today announces the end of the recruitment of patients in the second cohort of its clinical trial of phase 1/2 Audioge. In addition. The gene therapy developed by the company to treat a specific form of congenital deafness linked to mutations in. In addition, the OTOF gene (Otoferline). Similarly,
The recruitment of the second cohort. made up of three patients aged 6 to 31 months at the time of treatment was recently completed with. the injection of the third patient. Patients in this second cohort received, a unilateral meaning of Sens-501 at a dose of 4.5E11 VG/Vector/ear, dose higher than sensorion finalizes recruitment patients second new that of the first cohort (1.5E11 VG/Vector/ear). For sensorion finalizes recruitment patients second all patients treated in the first. second cohort, the surgical procedure has been tolerated: the intra-cochlear administration of the gene therapy proceeds took place without incident. No serious adverse event and no serious side effects have been reported. Early signs of improvement in hearing were observed in patients 3. 11 months old at the time of injection, three months after receiving the injection of the low dose of gene therapy.
sensorion finalizes recruitment patients second — Sensorion finalizes recruitment patients second: Montpellier. July 29, 2025, 7:30 am this-Sensorion (FR0012596468-Alsen), a pioneer company of biotechnology at the clinical stage, specialized in the development o.
Further reading: Walking 7000 steps a day is extremely beneficial for health, according to a study – Neutralizing human monoclonal antibodies against the hepatitis E virus – The best diets to restore transit – United Kingdom: Eight babies were born thanks to the DNA of three people – The prescriptions have doubled since 2020!.
Sensorion finalizes recruitment patients second new
Further reading: PRAC recommends a softening of hematological monitoring – A magnitude survey on the management of tinnitus in business – Qualitative exploratory analysis of the acceptability of HIV prevention methods in pregnant and lactating women interviewed during the randomized phase of purpose 1 – Anosmia, a precious indicator in Parkinson’s disease – Cynomel replaced by Thybon 20 Henning: Watch out for the risk of drug errors | The daily life of the pharmacist.
